Rapid and long-lasting effects of subcutaneous esketamine on suicidality: An open-label study in patients with treatment-resistant depression

Author:

Lopes Eduardo Igor Torquato CardosoORCID,Cavalcanti-Ribeiro Patrícia,Palhano-Fontes FernandaORCID,Gonçalves Kaike Thiê da Costa,Nunes Emerson ArcoverdeORCID,Lima Nicole Bezerra de MedeirosORCID,Santos Nestor Caetano,Brito Aldielyson Jorge Cavalcante deORCID,de Araujo Draulio Barros,Galvão-Coelho Nicole LeiteORCID

Publisher

Elsevier BV

Reference41 articles.

1. Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial;Abbar;BMJ,2022

2. Ketamine study: protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation;Anzolin;Front. Psychiatr.,2023

3. Intranasal esketamine (SpravatoTM) for use in treatment-resistant depression in conjunction with an oral antidepressant;Bahr;P T,2019

4. Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant;Ballard;J. Psychiatr. Res.,2015

5. Psychometric characteristics of the scale for suicide ideation with psychiatric outpatients;Beck;Behav. Res. Ther.,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3